Phase 2 study of the prophylactic antiviral activity of HEX17 via a HRV challenge model

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  1009713

• Contact name

  Claire Rothnie

• Contact email

  claire.rothnie@pneumagen.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Research summary

  Publication of this data is currently deferred.

• REC name

  East Midlands - Leicester Central Research Ethics Committee

• REC reference

  24/EM/0187

• Date of REC Opinion

  8 Oct 2024

• REC opinion

  Further Information Favourable Opinion